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In the previous issue of Critical Care, Vermeulen 
Windsant and colleagues demonstrate that transfusion of 
packed red cells is associated with a transient increase in 
plasma free haemoglobin and scavenging of nitric oxide 
(NO) in vitro [1]. They also demonstrate that older units 
of blood have more free haemoglobin in their super­
natants. The implication is that the possible but unproven 
adverse effects of older transfused blood may be due to 
the inadvertent administration of free haemoglobin, 
enhanced NO scavenging, and modified microvascular 
flow.
However, it is still unclear whether allogenic blood 
stored for longer periods of time has adverse effects for 
the recipient. Observational data demonstrate that the 
use of older blood in patients who have undergone 
cardiac surgery is associated with an increased mortality 
[2]. By contrast, others have demonstrated variable 
effects on physiological indices that are surrogates for 
organ perfusion [3,4]. These contrasting data and wide­
spread equipoise from clinicians have fuelled several 
clinical trials: the Age of Blood Evaluation Study 
(ISCRTN 44878718), the Red Cell Storage Duration 
Study (NCT00991341), and Red Cell Storage Duration 
and Outcomes in Cardiac Surgery (NCT00458783). 
These studies differ in their control groups and patient 
populations, with the first recruiting a wide group of 
critically ill patients and the latter two just examining 
those that have undergone cardiac surgery. Undoubtedly, 
the results of these studies will be of great interest to 
clinicians. The implications for the blood transfusion 
services, who typically issue the oldest blood to conserve 
precious and limited stocks, are immense.
The limitation of the present study is that only one 
mechanism of many is investigated and the link to 
adverse outcomes in patients is not considered [5,6]. 
Indeed, it is possible that several mechanisms exist, such 
as the administration of older more fragile erythrocytes, 
depletion of adenosine triphosphate and 2,3­diphos pho­
glycerate, or the presence of cytokines, histamine, and 
complement in supernatants. Furthermore, free haemo­
globin has other effects such as renal tubular toxicity and 
decompartmentalisation of iron, which may influence the 
redox balance, microbial killing, or intracellular signalling 
[7]. Finally, NO has roles other than that as mediator of 
vascular tone. Free haemoglobin and NO scavenging may 
thus be events that occur in parallel with other pheno­
mena. Nevertheless, nonselective inhibition of the NO 
pathway has been associated with increased mortality in 
sepsis [8] and the authors describe a very plausible 
mechanism. The physiological and biochemical readout 
from the aforementioned clinical trials will be key in our 
understanding and the current study will inform such 
analyses.
Important also is the authors’ observation that higher 
pre­transfusion haptoglobin levels appear to be protec tive 
in terms of a rise in free haemoglobin and NO scavenging. 
The implication is that the administration of haptoglobin 
may mitigate against any adverse effects of free 
haemoglobin, particularly in the setting of significant 
haemorrhage and cardiac surgery when levels are likely to 
be low. This is supported by the fact that free haemo globin 
appears to stay primarily in the blood compart ment in 
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conjunction with any administered haptoglobin. Quanti­
tatively, the rise in plasma free haemoglobin following a 
2­unit transfusion suggests that the free haemoglobin 
administered is diluted about 13­fold and that the volume 
of distribution is of the order of 7 l, similar to an adult’s 
total blood volume. Haemolysis may also be a significant 
contributor to organ dysfunction in other scenarios 
encountered in the critically ill: haemo globinopathies, 
severe infection (for example, malaria, Escherichia coli), 
cardiac valvular disease, and the use of extracorporeal 
therapies such as renal replacement therapy, cardio­
pulmo nary bypass, and extracorporeal membrane 
oxygenation.
Mechanisms are important. Clinicians often need to 
understand the rationale prior to changing practice. This 
study generates the hypothesis that free haemoglobin 
present in older blood may be detrimental by modulating 
the NO pathway, which merits consideration when 
clinical trials are evaluated.
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